Laura M Raffield1, Subhashish Agarwal1, Amanda J Cox1, Fang-Chi Hsu1, J Jeffrey Carr1, Barry I Freedman1, Jianzhao Xu1, Donald W Bowden1, Mara Z Vitolins1. 1. From the Molecular Genetics and Genomics Program (LMR), the Centers for Human Genomics (LMR, AJC, JX, and DWB) and Diabetes Research (LMR, AJC, JX, and DWB), and the Departments of Biochemistry (AJC and DWB), Biostatistical Sciences (F-CH), Internal Medicine-Nephrology (BIF), and Epidemiology & Prevention (MZV), Wake Forest School of Medicine, Winston-Salem, NC; the Department of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL (SA); and the Department of Radiology, Vanderbilt University Medical Center, Nashville, TN (JJC).
Abstract
BACKGROUND: The use of calcium supplements to prevent declines in bone mineral density and fractures is widespread in the United States, and thus reports of elevated cardiovascular disease (CVD) risk in users of calcium supplements are a major public health concern. Any elevation in CVD risk with calcium supplement use would be of particular concern in individuals with type 2 diabetes (T2D) because of increased risks of CVD and fractures observed in this population. OBJECTIVE: In this study, we examined associations between calcium intake from diet and supplements and measures of subclinical CVD (calcified plaque in the coronary artery, carotid artery, and abdominal aorta) and mortality in individuals affected by T2D. DESIGN: We performed a cross-sectional analysis in individuals affected by T2D from the family-based Diabetes Heart Study (n = 720). RESULTS: We observed no significant associations of calcium from diet or supplements with any of our measures of calcified plaque, and no greater mortality risk was observed with increased calcium intake. Instead, calcium supplement use was modestly associated with reduced all-cause mortality in women (HR: 0.62; 95% CI: 0.42, 0.92; P = 0.017). CONCLUSION: Our results do not support a substantial association between calcium intake from diet or supplements and CVD risk in individuals with T2D.
BACKGROUND: The use of calcium supplements to prevent declines in bone mineral density and fractures is widespread in the United States, and thus reports of elevated cardiovascular disease (CVD) risk in users of calcium supplements are a major public health concern. Any elevation in CVD risk with calcium supplement use would be of particular concern in individuals with type 2 diabetes (T2D) because of increased risks of CVD and fractures observed in this population. OBJECTIVE: In this study, we examined associations between calcium intake from diet and supplements and measures of subclinical CVD (calcified plaque in the coronary artery, carotid artery, and abdominal aorta) and mortality in individuals affected by T2D. DESIGN: We performed a cross-sectional analysis in individuals affected by T2D from the family-based Diabetes Heart Study (n = 720). RESULTS: We observed no significant associations of calcium from diet or supplements with any of our measures of calcified plaque, and no greater mortality risk was observed with increased calcium intake. Instead, calcium supplement use was modestly associated with reduced all-cause mortality in women (HR: 0.62; 95% CI: 0.42, 0.92; P = 0.017). CONCLUSION: Our results do not support a substantial association between calcium intake from diet or supplements and CVD risk in individuals with T2D.
Authors: J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano Journal: Radiology Date: 2005-01 Impact factor: 11.105
Authors: Leslie A Lange; Donald W Bowden; Carl D Langefeld; Lynne E Wagenknecht; J Jeffrey Carr; Stephen S Rich; Ward A Riley; Barry I Freedman Journal: Stroke Date: 2002-07 Impact factor: 7.914
Authors: Lisa Langsetmo; Claudie Berger; Nancy Kreiger; Christopher S Kovacs; David A Hanley; Sophie A Jamal; Susan J Whiting; Jacques Genest; Suzanne N Morin; Anthony Hodsman; Jerilynn C Prior; Brian Lentle; Millan S Patel; Jacques P Brown; Tassos Anastasiades; Tanveer Towheed; Robert G Josse; Alexandra Papaioannou; Jonathan D Adachi; William D Leslie; K Shawn Davison; David Goltzman Journal: J Clin Endocrinol Metab Date: 2013-05-23 Impact factor: 5.958
Authors: Janet A Foote; Suzanne P Murphy; Lynne R Wilkens; Jean H Hankin; Brian E Henderson; Laurence N Kolonel Journal: Am J Epidemiol Date: 2003-05-15 Impact factor: 4.897
Authors: Julie Anne Hoff; Lauretta Quinn; Alexander Sevrukov; Rebecca B Lipton; Martha Daviglus; Daniel B Garside; Niraj K Ajmere; Sanjay Gandhi; George T Kondos Journal: J Am Coll Cardiol Date: 2003-03-19 Impact factor: 24.094
Authors: L M Raffield; S Agarwal; F C Hsu; I H de Boer; J H Ix; D Siscovick; M Szklo; G L Burke; A C Frazier-Wood; D M Herrington Journal: Nutr Metab Cardiovasc Dis Date: 2016-07-16 Impact factor: 4.222
Authors: Alisson Diego Machado; Luz Marina Gómez; Dirce Maria Lobo Marchioni; Fernanda Silva Nogueira Dos Anjos; Maria Del Carmen Bisi Molina; Paulo Andrade Lotufo; Isabela Judith Martins Benseñor; Silvia Maria de Oliveira Titan Journal: Nutrients Date: 2018-03-19 Impact factor: 5.717